European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 15 June 2026 - 12:00

Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Tecovirimat SIGA, tecovirimat monohydrate, Date of authorisation: 06/01/2022, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 15 June 2026 - 11:06

Human medicines European public assessment report (EPAR): Tecovirimat SIGA, tecovirimat monohydrate, Date of authorisation: 06/01/2022, Revision: 6, Status: Authorised

Webinar on the use of platform approaches in the non-clinical and clinical domains, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 March 2026, 09:25 (CET) to 2 March 2026, 12:30 (CET)

Submitted by Anonymous (not verified) on 15 June 2026 - 11:00

Webinar on the use of platform approaches in the non-clinical and clinical domains, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 March 2026, 09:25 (CET) to 2 March 2026, 12:30 (CET)

Committee for Medicinal Products for Veterinary Use (CVMP): 10-12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, from 10 March 2026 to 12 March 2026

Submitted by Anonymous (not verified) on 15 June 2026 - 10:57

Committee for Medicinal Products for Veterinary Use (CVMP): 10-12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, from 10 March 2026 to 12 March 2026

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness